These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3261263)

  • 21. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular responses to exercise in the rat: role of corticotropin-releasing factor.
    Kregel KC; Overton JM; Seals DR; Tipton CM; Fisher LA
    J Appl Physiol (1985); 1990 Feb; 68(2):561-7. PubMed ID: 2318769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides.
    Overton JM; Fisher LA
    Brain Res; 1989 May; 488(1-2):233-40. PubMed ID: 2568150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats.
    Jin R; Li MZ; Bing YH; Piao RL; Li YJ; Jin QH; Qiu DL; Kannan H; Chu CP
    Regul Pept; 2013 Sep; 186():7-11. PubMed ID: 23850799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic corticotrophin-releasing factor and norepinephrine mediate sympathetic and cardiovascular responses to acute intracarotid injection of tumour necrosis factor-alpha in the rat.
    Zhang ZH; Felder RB
    J Neuroendocrinol; 2008 Aug; 20(8):978-87. PubMed ID: 18777604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of central serotonergic (5-HT2) receptor in blood pressure regulation in rats.
    Kushiro T; Kurumatani H; Ishii T; Yokoyama H; Koike J; Hatayama Y; Kobayashi Y; Kajiwara N
    Clin Exp Hypertens A; 1988; 10 Suppl 1():339-45. PubMed ID: 3243000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system cardiovascular actions of CRF in sinoaortic-denervated rats.
    Overton JM; Davis-Gorman G; Fisher LA
    Am J Physiol; 1990 Mar; 258(3 Pt 2):R596-601. PubMed ID: 2316708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity.
    Overton JM; Fisher LA
    Regul Pept; 1989; 25(3):315-24. PubMed ID: 2788898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pavlovian conditioning of corticotropin-releasing factor-induced increase of blood pressure and corticosterone secretion in the rat.
    Kreutz M; Hellhammer D; Murison R; Vetter H; Krause U; Lehnert H
    Acta Physiol Scand; 1992 May; 145(1):59-63. PubMed ID: 1502913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
    Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor.
    Dedeoğlu A; Fisher LA
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R859-64. PubMed ID: 8092332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of ketanserin on blood pressure in rats].
    Sano M; Minami M; Togashi H; Yoshioka M; Tochihara M; Hirokami M; Saito H
    Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):401-9. PubMed ID: 2419229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central corticotropin releasing factor (CRF) and adrenergic receptors mediate hemodynamic responses to cocaine.
    Dong HW; Gan Q; Knuepfer MM
    Brain Res; 2001 Mar; 893(1-2):1-10. PubMed ID: 11222986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
    Mollace V; De Francesco EA; Fersini G; Nisticò G
    Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.
    Persson B; Hedner T; Henning M
    J Pharm Pharmacol; 1982 Jul; 34(7):442-5. PubMed ID: 6126541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].
    Makarenko EIu; Andreeva LA; Borovik AS; Mart'ianov AA
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):71-9. PubMed ID: 15773582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
    Fisher L; Rivier C; Rivier J; Brown M
    Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.